Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026)
Jade Biosciences (JBIO) recorded Non-Current Assets of $862,000 in Q2 2026, down 12.4% from $984,000 a year earlier and down 5.9% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Jade Biosciences reported Non-Current Assets of $965,000, down 69.3% from FY2024.
- Annual Non-Current Assets has declined for three straight years, though with a five-year compound annual growth rate of 90.0% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $3.15 million in FY2024 (-1.3%), $3.19 million in FY2023 (-16.3%), $3.81 million in FY2022 (+269.4%) and $1.03 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in three of the last eight quarters, with growth averaging 52.3%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 472.5% in Q1 2026, against a decline of 95.5% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $916,000 (Q1 2026), $965,000 (Q4 2025) and $1.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Jade Biosciences | 955.84 Mn | -351.78 Mn | - | 862,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 862,000.00 |
| Mar 31, 2026 | 916,000.00 |
| Dec 31, 2025 | 965,000.00 |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 984,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 934,000.00 |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 3.29 Mn |
| Mar 31, 2023 | 3.82 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 2.24 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.02 Mn |
API Access
Jade Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();